Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer survivors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 39
Healthy Volunteers: f
View:

• Is currently between the ages of 18-39 years

• Their primary brain tumor was diagnosed at age 15-39 years

• Is 6 months to \<5 years post curative treatment

• Has been treated with chemotherapy and radiation, given most patients receive both therapies.

• Functional Assessment of Chronic Illness therapy (FACIT)-Fatigue ≤ 43. FACIT-Fatigue will be used as a screener because this 13-item scale can be completed relatively quickly in clinic

• Currently engage in \<150 minutes of PA and \< 2 sessions of muscle strengthening exercise per week (assessed by Godin Leisure-Time PA Questionnaire)

• Must be able to speak, write, and read English

• No exercise contraindication as assessed by screening with the Physical Activity Readiness Questionnaire PAR-Q+. In addition, participants' care teams will be notified of their participation in the study.

• Must be able to provide informed consent/assent.

Locations
United States
Texas
The University of Texas M. D. Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Michael Roth, MD
mroth1@mdanderson.org
(713) 792-7751
Time Frame
Start Date: 2025-09-09
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 75
Treatments
Experimental: Attention Control Group
Participants will randomized using incorrect baseline information.
Experimental: InItervention Group: Remote Implementation of Supervised Exercise for Young Adult
Participants will randomized using incorrect baseline information.
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center
Collaborators: Cancer Prevention Research Institute of Texas

This content was sourced from clinicaltrials.gov